These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8665843)

  • 1. The IVS6 segment of the L-type calcium channel is critical for the action of dihydropyridines and phenylalkylamines.
    Schuster A; Lacinová L; Klugbauer N; Ito H; Birnbaumer L; Hofmann F
    EMBO J; 1996 May; 15(10):2365-70. PubMed ID: 8665843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinctions in the molecular determinants of charged and neutral dihydropyridine block of L-type calcium channels.
    Lacinová L; An RH; Xia J; Ito H; Klugbauer N; Triggle D; Hofmann F; Kass RS
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1472-9. PubMed ID: 10336541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
    Zahradníková A; Minarovic I; Zahradník I
    J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain.
    Huber I; Wappl E; Herzog A; Mitterdorfer J; Glossmann H; Langer T; Striessnig J
    Biochem J; 2000 May; 347 Pt 3(Pt 3):829-36. PubMed ID: 10769189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfer of the high affinity dihydropyridine sensitivity from L-type To non-L-type calcium channel.
    Ito H; Klugbauer N; Hofmann F
    Mol Pharmacol; 1997 Oct; 52(4):735-40. PubMed ID: 9380037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct effects of mutations in transmembrane segment IVS6 on block of L-type calcium channels by structurally similar phenylalkylamines.
    Johnson BD; Hockerman GH; Scheuer T; Catterall WA
    Mol Pharmacol; 1996 Nov; 50(5):1388-400. PubMed ID: 8913371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key roles of Phe1112 and Ser1115 in the pore-forming IIIS5-S6 linker of L-type Ca2+ channel alpha1C subunit (CaV 1.2) in binding of dihydropyridines and action of Ca2+ channel agonists.
    Yamaguchi S; Zhorov BS; Yoshioka K; Nagao T; Ichijo H; Adachi-Akahane S
    Mol Pharmacol; 2003 Aug; 64(2):235-48. PubMed ID: 12869628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voltage-dependent calcium channels.
    Lacinová L
    Gen Physiol Biophys; 2005 Jun; 24 Suppl 1():1-78. PubMed ID: 16096350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological, radioligand binding, and electrophysiological characteristics of FPL 64176, a novel nondihydropyridine Ca2+ channel activator, in cardiac and vascular preparations.
    Zheng W; Rampe D; Triggle DJ
    Mol Pharmacol; 1991 Nov; 40(5):734-41. PubMed ID: 1719369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium channel block by (-)devapamil is affected by the sequence environment and composition of the phenylalkylamine receptor site.
    Degtiar VE; Aczél S; Döring F; Timin EN; Berjukow S; Kimball D; Mitterdorfer J; Hering S
    Biophys J; 1997 Jul; 73(1):157-67. PubMed ID: 9199780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of dihydropyridine binding residues in a less sensitive invertebrate L-type calcium channel (LCa v 1).
    Senatore A; Boone A; Lam S; Dawson TF; Zhorov B; Spafford JD
    Channels (Austin); 2011; 5(2):173-87. PubMed ID: 21487241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Ro 40-5967 and verapamil with the stably expressed alpha 1-subunit of the cardiac L-type calcium channel.
    Lacinová L; Welling A; Bosse E; Ruth P; Flockerzi V; Hofmann F
    J Pharmacol Exp Ther; 1995 Jul; 274(1):54-63. PubMed ID: 7616442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of recombinant Ca2+ channels by benzothiazepines and phenylalkylamines: class-specific pharmacology and underlying molecular determinants.
    Cai D; Mulle JG; Yue DT
    Mol Pharmacol; 1997 May; 51(5):872-81. PubMed ID: 9145926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceleration of activation and inactivation by the beta subunit of the skeletal muscle calcium channel.
    Varadi G; Lory P; Schultz D; Varadi M; Schwartz A
    Nature; 1991 Jul; 352(6331):159-62. PubMed ID: 1712427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and functional characterization of a novel human low-voltage activated calcium channel.
    Williams ME; Washburn MS; Hans M; Urrutia A; Brust PF; Prodanovich P; Harpold MM; Stauderman KA
    J Neurochem; 1999 Feb; 72(2):791-9. PubMed ID: 9930755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human vascular to cardiac tissue selectivity of L- and T-type calcium channel antagonists.
    Sarsero D; Fujiwara T; Molenaar P; Angus JA
    Br J Pharmacol; 1998 Sep; 125(1):109-19. PubMed ID: 9776350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verapamil inhibits L-type calcium channel mediated apoptosis in human colon cancer cells.
    Zawadzki A; Liu Q; Wang Y; Melander A; Jeppsson B; Thorlacius H
    Dis Colon Rectum; 2008 Nov; 51(11):1696-702. PubMed ID: 18575938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels.
    Grabner M; Wang Z; Hering S; Striessnig J; Glossmann H
    Neuron; 1996 Jan; 16(1):207-18. PubMed ID: 8562085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term down-regulation of dihydropyridine receptors by Bay K 8644 in PC12 cells.
    Nikodijevic B; Nikodijevic-Kedeva D; Oshima M; Paige B; Guroff G
    J Neurosci Res; 1994 Jan; 37(1):71-82. PubMed ID: 7511705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cav1.4alpha1 subunits can form slowly inactivating dihydropyridine-sensitive L-type Ca2+ channels lacking Ca2+-dependent inactivation.
    Koschak A; Reimer D; Walter D; Hoda JC; Heinzle T; Grabner M; Striessnig J
    J Neurosci; 2003 Jul; 23(14):6041-9. PubMed ID: 12853422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.